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Abstract 
Background 
Vitamin D deficiency is associated with physiologic changes that are similar to pathogenesis of 
preeclampsia. Although association of vitamin D and preeclampsia has been studied previously, their 
results are not consistent. The aim of this study was to investigate the relationship of serum vitamin D 
and calcium with preeclampsia severity.  
Materials and Methods: This case- control study was conducted in 75 healthy pregnant women and 
74 pregnant women with preeclampsia (46 mild preeclampsia and 28 severe preeclampsia) in Qazvin, 
Iran in 2015. Serum vitamin D, calcium, and albumin were measured; corrected calcium was also 
calculated. Hypocalcemia and vitamin D deficiency were compared between the groups. Logistic 
regression analysis was used to study the independent association of hypocalcemia and 
hypovitaminosis D with preeclampsia.  
Results  
Mean serum vitamin D level was 27.7±15.3, 22.9±15.9, and 27.6±16.6 in normal, mild preeclampsia, 
and severe preeclampsia groups (P> 0.05); also vitamin D deficiency was not different between the 
groups. Hypocalcemia in severe preeclampsia group was more frequent than normal group (25.9% vs. 
6.6%, P: 0.017). Hypocalcemia was associated with severe preeclampsia after adjustment for age, 
parity, and calcium supplement consumption (OR: 6.7, 95% CI: 1.45-30.79; P: 0.015).  
Conclusion 
There was not any association between vitamin D deficiency  and preeclampsia in the present study, 
however low corrected serum calcium was associated with about six times increased risk of sever 
preeclampsia. More studies are needed to determine the role of hypocalcemia and vitamin D in 
preeclampsia.  
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1- INTRODUCTION 
     Preeclampsia is a major complication 
that occurs in 3-7% of pregnancies (1). In a 
meta-analysis, the overall prevalence of 
preeclampsia was 5% in Iran and the 
prevalence of preeclampsia was increased 
from 4% (95% CI: 3%-5%) during 1996 to 
2005 to 7% (95% CI: 4%-9%) during 2010 
to 2013 (2). Reduced placental perfusion 
occurs in the early stages of preeclampsia. 
This change cause cytokines and other 
inflammatory materials release that affect 
different organs and results in a triad 
including hypertension, proteinuria, and 
edema (3). Vitamin D deficiency is 
associated with physiologic changes such 
as altered endothelium function and 
increased cytokine levels (4) that are 
similar to pathogenesis of preeclampsia. 
Vitamin D is also a major suppressor of 
rennin synthesis. Vitamin D deficiency can 
increase rennin secretion that causes 
increased blood pressure (5). Vitamin D 
improves tissue perfusion through decrease 
in vascular smooth muscle hyperplasia, 
decrease in insulin resistance, and 
improvement in endothelial function (6). 
In addition, vitamin D modulates immune 
system and regulates macrophages 
function and cytokines release (4). 
Placental 1-α hydroxylase convert vitamin 
D to the active form (7). There are Vitamin 
D receptors in placenta that justify the 
autocrine role of vitamin D in regulation of 
placental functions (8). Vitamin D 
deficiency is prevalent among pregnant 
women especially in developing countries. 
The prevalence of vitamin D deficiency is 
about 80% in Iran (9). Although, 
association of vitamin D and preeclampsia 
has been studied previously, their results 
are not consistent. In some studies 
preeclampsia has been associated with 
greater frequency of vitamin D deficiency, 
while no association has been reported in 
other studies. Surprisingly, in one study, 
pregnancy hypertension was associated 
with higher vitamin D level (10). The aim 
of this study was to investigate the 
association of serum vitamin D and 
calcium with preeclampsia severity in 
pregnant women. 
2- MATERIALS AND METHODS 
2-1. Study design and population 
     This case control study was conducted 
in 75 healthy pregnant women and 74 
pregnant women with preeclampsia who 
referred to the Kowsar Hospital affiliated 
to Qazvin University of Medical Sciences, 
Iran, in 2015.  
2-2. Methods 
Pregnant women with diagnosis of late 
preeclampsia were considered as case 
group (n=74), from March to May 2015. 
Healthy pregnant women, referred for 
delivery were considered as control group 
(n=75), and were matched for age, 
gestational age, parity, season, and place 
of residence. Pregnant women with 
preeclampsia were classified as mild and 
severe preeclampsia.  
Mild preeclampsia was defined as 140/90 
< Blood pressure < 160/110 in both 
measurements and proteinuria after 20 
weeks of gestation. Proteinuria was 
defined as protein ≥ 300 mg in 24 hours 
urine sample.  
Severe preeclampsia was identified when 
at least one of the following conditions 
were met: Blood pressure ≥ 160/110, 2 
grams proteinuria in 24 hours urine 
sample, more than 2 + protein in urine 
dipstick, creatinine (Cr) > 1.2 mg/dl 
without previous history of Cr rise, 
platelets fall below 100,000 per microliter 
of blood, microangiopathic hemolysis, and 
increased serum transaminase (11). 
2-3. Measuring tools  
Data were collected through a 
questionnaire including demographics 
variables, gestational age, history of 
vitamin D and calcium supplement 
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consumption, season of sampling, and 
body mass index (BMI). All 
anthropometric indices were measured by 
a gynecologist. The height was measured 
in barefoot standing position using a wall 
mounted stadiometer Seca nearest 1 mm. 
The weight was also measured using Seca 
scale (Vogel and Halke, Hamburg, 
Germany), nearest 100 grams. The BMI 
was calculated as weight (kilograms) per 
height (meters) squared. Blood pressure 
(BP) was measured twice in a seated 
position using a mercury 
sphygmomanometer.   
measurements Laboratory 4.-2 
During admission period, 5ml venous 
blood sample was collected to measure 
serum vitamin D, calcium, and albumin. 
Fasting Urine calcium/creatinine ratio was 
calculated. All samples were analyzed in 
the Kowsar hospital laboratory.  
Vitamin D was measured by ELISA 
method using MAN Co kit. Inter-assay and 
intra-assay coefficient of variations (CVs), 
were 1.9% and 1.1%, respectively. 
Vitamin D deficiency was defined as 25 
(OH) D ≤ 50 nmol/l, and sever vitamin D 
deficiency was defined as 25 (OH) D ≤ 25 
nmol/l (12).  
Calcium was measured by calorimetric 
method using Pars Azmoon kit. Inter-assay 
and intra-assay CVs, were 2.7% and 1.4%, 
respectively. Albumin was measured by 
calorimetric method using Zistchem kit. 
Inter-assay and intra-assay CV, were 1.4% 
and 1.1%, respectively. Creatinine was 
measured by calorimetric method using 
Pars Azmoon kit.  
Corrected calcium was calculated by 
formula: serum calcium (mg/dL) + 0.8 * 
[4.0 – serum albumin (g/dL)]. Based on 
the reference range of calcium in Pars 
Azmoon kit, using Arsenazo reagent, 
hypocalcemia was defined as corrected 
calcium less than 8.3mg/dl.  
2.5-Ethical consideration 
The study protocol was confirmed in the 
ethics committee of Qazvin University of 
Medical Sciences (ID number: 
28/20/8285). The participants gave their 
written informed consent.  
2-6. Inclusion and exclusion criteria 
The inclusion criterion was diagnosis of 
late preeclampsia. The exclusion criteria 
were diabetes mellitus, multiple 
pregnancy, major fetal anomaly, history of 
chronic hypertension, underline diseases 
including cardiovascular diseases, liver 
diseases, thyroid disorders, and chronic 
renal insufficiency, known thrombophilia, 
and using anticonvulsant drugs.  
2-7. Data Analyses  
Kolmogorov Smirnov test was used to 
examine the normality of variables. Data 
were described as mean ± standard 
deviation (SD) for quantitative variables or 
as frequency for categorical variables. 
ANOVA was used for analysis of normally 
distributed continuous variables and non-
normally distributed variables were 
compared by Kruskal Wallis.  
Categorical variables were analyzed using 
Chi-square test. The independent 
association of hypocalcemia and vitamin D 
levels with preeclampsia was studied using 
logistic regression analysis. P-value less 
than 0.05 were considered as significant. 
3- RESULTS 
     The present study was conducted in 75 
healthy pregnant women and 74 pregnant 
women with preeclampsia (46 (62.16 %) 
with mild preeclampsia and 28 (37.84 %) 
with severe preeclampsia). Baseline 
characteristics of the study subjects are 
shown in Table.1.  
Age, body mass index, parity, and calcium 
supplement consumption was not different 
between the groups (P>0.05). All study 
participants received multivitamin tablets 
including 400 IU vitamin D according to 
the national prenatal care protocol. Clinical 
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and biochemical characteristics of the study 
subjects are shown in Table.2. Mean 
serum vitamin D level was not 
significantly different between the groups. 
85% of the study subjects had vitamin D 
insufficiency. The frequency of vitamin D 
insufficiency and vitamin D deficiency 
was not different between the groups. 
Based on corrected serum calcium level, 
25.9% of the pregnant women with severe 
preeclampsia had hypocalcemia that was 
significantly higher than normal group 
(P=0.017). In multinomial logistic 
regression analysis, hypocalcemia was 
associated with severe preeclampsia after 
adjustment for age, parity, gestational age, 
BMI, and calcium supplement 
consumption (Table. 3). 
 
   Table-1: Baseline characteristics of the study subjects 
Variables Total (n=149) 
Age (year) [mean ± SD] 28.5±5.9 
Body mass index (Kg/m2) [mean ± SD] 29.4±5.1 
Parity (number) [mean ± SD] 2.2±1.2 
Gestational age (weeks) [mean ± SD] 37.9±3.6 
Place of Residence  
Rural 34.9% 
urban 65.1% 
Sampling time  
March  14.8% 
April  44.3% 
May 40.9% 
Calcium supplement  20% 
SD: Standard deviation. 
Table-2: Clinical and biochemical characteristics of the study subjects 
Variables 
Normal 
(n=75) 
Preeclampsia 
(n=74) 
P-value† 
Mild 
Preeclampsia 
(n=46) 
Severe 
Preeclampsia 
(n=28) 
P-
value†† 
25(OH)D a nmol/l 27.7±15.3 24.7±16.2 0.239 22.9±15.9 27.6±16.6 0.22 
25(OH)D<25nmol/l b 52 61.3 0.249 64.6 55.5 0.386 
25(OH)D<50nmol/l b 86.6 92 0.290 91.6 92.6 0.567 
Corrected calcium a 8.9±0.4 8.7±0.4 0.182 8.8±0.3 8.7±0.4 0.21 
Hypocalcemia b 6.6 14.6 0.113 8.3 25.9 0.017* 
Urine Calcium to creatinine 
ratio a 
0.22±0.1 0.21±0.1 0.626 0.22±0.08 0.18±0.08 0.465 
Systolic blood pressure a 
(mmHg) 
112.6±9.1 151.3±13.3 0.005 144.1±8.8 164.3±9.7 0.001** 
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Diastolic blood pressure a 
(mmHg) 
71.6±7.1 97.0±13.3 0.002 91.1±8.4 107.4±13.5 0.001** 
a Data are presented as mean ± SD; b Data are presented as percent; † Comparison of normal group and 
preeclampsia group; †† Comparison of normal group and preeclampsia subgroups; *Difference was related to 
normal group and severe preeclampsia subgroup; **Difference was related to normal group and both 
preeclampsia subgroups. 
Table-3: Multinomial logistic regression for vitamin D deficiency and hypocalcemia as predictors of 
mild and sever preeclampsia 
Variables 
Odds ratio* 95% CI P-value 
Mild preeclampsia 
Hypovitaminosis D 1.86 0.43-7.98 0.404 
Hypoclacemia 1.70 0.34-8.4 0.515 
Sever preeclampsia 
Hypovitaminosis D 1.97 0.35-10.9 0.436 
hypocalcemia 6.68 1.45-30.79 0.015 
  * Adjusted for age, gestational age, BMI, and calcium supplement consumption. 
4- DISCUSSION 
    In the present study, mean vitamin D 
level was not different between the 
preeclampcia and normal groups. After 
adjustment for age, gestational age, BMI, 
and supplement consumption, the 
difference of mean vitamin D level was 
not significant between the groups, too. 
The corrected hypocalcemia in pregnant 
women with severe preeclampsia was 
more frequent than other two groups. After 
adjustment for age, parity, gestational age, 
BMI, and calcium supplement 
consumption, hypocalcemia was 
associated with six times increased risk of 
severe preeclampsia. 
In recent years, the role of vitamin D 
deficiency as a precipitating factor of 
preeclampsia has been studied with 
regards to common pathophysiologic 
mechanisms of vitamin D deficiency and 
preeclampsia (changes in vascular 
endothelium and renin–angiotensin system 
(RAS), and increase in inflammatory 
mediators), and presence of vitamin D 
receptors on placenta. Despite the higher 
prevalence of vitamin D deficiency in 
patients with preeclampsia in some studies, 
the results are not consistent. Previous 
studies are different regarding to their 
design. These studies can be categorized as 
nested case control studies and case 
control studies. In the nested case control 
studies, mostly the relationship of vitamin 
D level in 3-6 months of pregnancy and 
occurrence of preeclampsia in the last 
weeks of pregnancy has been investigated. 
Some of these studies reported higher rate 
of vitamin D deficiency in preeclampsia 
group compared to normal group (13-15).  
But, the cut off point for definition of 
vitamin D deficiency was different from 
30 nmol/L (15) to 50 nmol/L (13). 
However, the relationship of vitamin D 
level in the first trimester of pregnancy and 
preeclampsia has not been confirmed in 
other nested case control studies. In a 
study in Shiraz- Iran, the difference of 
vitamin D level was not significant 
between preeclampsia and healthy women 
while serum calcium level in preeclampsia 
women was lower than the normal women 
(16). Other studies conducted in UK, 
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Spain, Poland, and USA failed to find a 
significant association between vitamin D 
and preeclampsia (17-21). The results of 
case control studies are also inconsistent. 
Some studies have reported lower vitamin 
D level in preeclampsia group in the time 
of preeclampsia occurrence (22-24), but in 
another study such difference has not been 
found (25). In a meta-analysis of published 
studies until 2012 by Tabesh et al., vitamin 
D level < 50 ng/ml was associated with 
increased risk of preeclampsia, but in sub-
group analysis, the difference was only 
significant in studies of American 
population (26).  
Pathophysiologic processes ended to 
preeclampsia are originated in the first half 
of pregnancy. Therefore, nested case 
control studies can find more precisely 
association of any contributing factors 
with preeclampsia. But the present study 
had a case control design. The second 
reason could be attributed to the season of 
sampling. In the present study, sample 
selection was performed in late winter and 
early spring. So, the first trimester of the 
pregnancy which is critical for 
pathophysiology of preeclampsia was 
mainly in the sunny months, and vitamin D 
level were possibly higher in these months. 
Ethnicity can be other reason for such 
differences. As mentioned above, in meta- 
analysis of well-designed studies by 
Tabesh et al., lower vitamin D level in 
women with preeclampsia was only 
detected in American population (26). It 
seems that the relationship of vitamin D 
level and preeclmpsia is not simple and 
other related hormones and minerals may 
play roles in the occurrence of 
preeclampsia that results in differences of 
mentioned studies.  
Placenta convert 25(OH) D to 1, 25 (OH) 
D by placental 1alfa hydroxylase. This 
activated form of vitamin D has paracrine 
function. In addition, 1, 25 (OH) D and 
calcium are major modulators of 
parathormone (PTH). However, few 
studies have focused on the complex 
association of serum 1, 25 (OH) D, 
calcium, and PTH with preeclampsia. In 
the present study, the prevalence of 
hypocalcemia in patients with severe 
preeclampsia was significantly higher than 
other groups. The relationship of serum 
calcium with preeclamsia have been 
investigated in limited studies. In two 
studies, serum calcium in patients with 
preeclampsia was lower than normal 
subjects (27, 28). 
The cause and effect association of 
hypocalcemia and preeclampsia has not 
been established. Hypocalcemia can be 
considered the result of preeclampsia as a 
critical illness. On the other hand, 
complications of hypocalcemia e.g. 
secondary hyperparathyroidism may play a 
role in the etiology of preeclampsia (29).  
Few studies have investigated the 
association of PTH and preeclampsia. In 
Seely et al. study, vitamin D level was 
similar in preeclampsia and normal group; 
but PTH level in preeclampsia was about 
two times higher than normal group while 
1, 25 (OH) D in preeclampsia was lower 
than normal group (30). PTH level had 
negative correlation with serum and urine 
calcium. In a cohort study on 1141 
pregnant women by Scholl et al., 
preeclampsia was more prevalent in cases 
that had higher PTH level simultaneously 
(31). These results indicate the potential 
role of PTH in pathogenesis of 
preeclampsia.  
4-1. Limitations of the study 
The present study had some limitations 
including the time of blood sampling that 
was at preeclampsia occurrence while 
pathogenesis of preeclampsia begins from 
weeks to months prior to the preeclampsia. 
5- CONCLUSION 
     In summary, there was not any 
relationship between vitamin D deficiency  
and preeclampsia in the present study, but 
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low corrected serum calcium was 
associated with about six times increased 
risk of sever preeclampsia. More studies 
are needed to determine the role of 
hypocalcemia and vitamin D in 
preeclampsia. 
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